CASIF · CASI Pharmaceuticals, Inc. · Documents
Market Cap
$2.06M
Shares
20.56M
Volume · Oct 20
500
Avg daily vol (3M)
2378
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2024-06-27 | — | |
| 6-K | — | 2024-05-15 | 2024-05-14 | |
| 6-K | — | 2024-04-08 | — | |
| 6-K | — | 2024-03-28 | — | |
| 20-F | — | 2024-03-28 | 2023-12-31 | |
| 6-K | — | 2024-03-13 | — | |
| 6-K | — | 2024-02-29 | — | |
| 6-K | — | 2024-02-12 | 2024-02-09 | |
| 6-K | — | 2024-01-30 | 2024-01-29 | |
| 6-K | — | 2023-12-15 | — | |
| 6-K | — | 2023-12-08 | 2023-12-06 | |
| 6-K | — | 2023-11-14 | — | |
| 6-K | — | 2023-11-08 | — | |
| 6-K | — | 2023-08-11 | — | |
| 6-K | — | 2023-08-01 | — | |
| 6-K | — | 2023-07-20 | — | |
| 6-K | — | 2023-05-17 | — | |
| 6-K | — | 2023-05-17 | — | |
| 6-K | — | 2023-04-26 | — | |
| 20-F | — | 2023-04-26 | 2022-12-31 | |
| 6-K | — | 2023-04-26 | — | |
| 6-K | — | 2023-03-21 | — |
Showing 51–72 of 72 filings